Drawing for AI-BOOST AFFINITY

USPTO serial 79414786

AI-BOOST AFFINITY

Reviewed by CopyMark Law Group

Status 402
Filing date
Status date
Registration date
Examiner
FLETCHER, TRACY L
Law office
TMO LAW OFFICE 115

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with AI-BOOST AFFINITY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Computer software used in the context of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; computer software used in the context of antibody discovery and identification; artificial intelligence software used in the context of drug discovery, affinity maturation, engineering of biological products, studies of molecular interactions, humanization and identification, drug research, antibody research and design, pharmaceutical research; machine learning software used in the context of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; downloadable software for research, diagnostics, genomics, proteomics, omics and biological products; big data generating software.SECTION 70 - CANCELLED
042Software as a service [SaaS] for a use in the field of drug discovery, diagnostics, genetics, proteomics and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals, pharmaceutical research; medicine discovery services; biological research; scientific services and research in the field of drug discovery, affinity maturation, biological product engineering, studies of molecular interactions, humanization and identification, drug research, antibody, protein, peptide, biological and chemical research and design, pharmaceutical research; antibody sequencing; Research and development services related to AI in the field of drug discovery and identification, drug research, antibody research and design, pharmaceutical research; research and development in the field of drug discovery and identification, drug research, research and design of antibodies, proteins, peptides, biological products and chemicals; research and development services in the field of antibody technology; electronic data storage; Software as a Service [SaaS] including software for machine learning.SECTION 70 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 9, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 15, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 15, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Oct 10, 2025DETHDEATH OF INTERNATIONAL REGISTRATION
Jun 13, 2025RFNTREFUSAL PROCESSED BY IB
May 24, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 24, 2025RFRRREFUSAL PROCESSED BY MPU
Mar 27, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 26, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2025DOCKASSIGNED TO EXAMINER
Jan 17, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Jan 16, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 16, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance